ump8k103008.htm
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
Pursuant
to Section 13 or 15(d) of
The
Securities Exchange Act of 1934
Date of
Report (date of earliest event reported): October 30, 2008
Commission File No. 0-11178
UTAH MEDICAL PRODUCTS,
INC.
(Exact
name of Registrant as specified in its charter)
UTAH
|
87-0342734
|
(State
or other jurisdiction of
|
(I.R.S.
Employer
|
incorporation
or organization)
|
Identification
No.)
|
7043
South 300 West
Midvale,
Utah 84047
Address
of principal executive offices
Registrant's
telephone number: (801)
566-1200
On
October 30, 2008, Utah Medical Products, Inc. announced that it is increasing
its regular quarterly cash dividend. A dividend of $.230 per share is
payable on January 5, 2009 to shareholders of record at the close of business on
December 16, 2008. A copy of the press release is attached hereto as
Exhibit 99.1
Pursuant
to the requirements of the Securities Exchanges Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
|
UTAH MEDICAL PRODUCTS,
INC.
|
|
REGISTRANT
|
|
|
|
|
|
|
Date:
10/30/2008
|
By:
|
/s/ Kevin
L. Cornwell
|
|
|
Kevin
L. Cornwell
|
|
|
CEO
|